Residency

Medical schools take strong stance on drug company relationships

Residency Program Insider, July 7, 2009

Want to receive articles like this one in your inbox? Subscribe to Residency Program Insider!

More medical schools this year received higher scores on the American Medical Student Association (AMSA) PharmFree Scorecard. The PharmFree Scorecard grades medical schools’ conflict of interest policies, specifically looking at the rules for industry giving gifts, meals, free drug samples, and payment for speaking engagements to physicians, as well as physician interaction with industry representatives and industry-funded education.

According to AMSA, 45 of 149 medical schools received an A or B grade in 2009, up from only 29 schools which scored in that range last year. Of the 35 schools that received an F, 23 did not submit their policy for review and were automatically given the low grade. Thirty-four schools were deemed “in process” because the AMSA is still reviewing their policies, said an AMSA press release.



Want to receive articles like this one in your inbox? Subscribe to Residency Program Insider!